Galectin Therapeutics
GALT
GALT
58 hedge funds and large institutions have $5.88M invested in Galectin Therapeutics in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% less capital invested
Capital invested by funds: $7.02M → $5.88M (-$1.14M)
Holders
58
Holding in Top 10
–
Calls
$819K
Puts
$73K
Top Buyers
| 1 | +$1.78M | |
| 2 | +$95.1K | |
| 3 | +$59.8K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$53K |
| 5 |
AIG
American International Group
New York
|
+$52.5K |
Top Sellers
| 1 | -$670K | |
| 2 | -$107K | |
| 3 | -$88.4K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$35.8K |
| 5 |
Goldman Sachs
New York
|
-$30.9K |